Malin-backed Poseida Therapeutics files for IPO on Nasdaq exchange
Poseida is one of four priority assets in which the life sciences company has stakes
Malin-backed biotech company raises $142m
Poseida Therapeutics uses genome engineering to develop cancer treatments
Dublin-listed Malin secures €70m debt facility from EIB
Company to use facility to increase investments in European life sciences sector
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices